刺
癌症研究
肿瘤微环境
细胞因子信号抑制因子1
干扰素基因刺激剂
细胞生物学
细胞因子
免疫疗法
癌症免疫疗法
免疫学
先天免疫系统
车站3
医学
生物
免疫系统
信号转导
癌症
抑制器
内科学
航空航天工程
工程类
作者
Chuan-xia Zhang,Shu-Biao Ye,Jian-jiao Ni,Tingting Cai,Yi-Na Liu,Dai-jia Huang,Hai-Qiang Mai,Qiu-Yan Chen,Jia He,Xiao-Shi Zhang,Yi-Xin Zeng,Jiang Li,Jun Cui
标识
DOI:10.1038/s41418-019-0302-0
摘要
Stimulator of interferon genes (STING), a major adaptor protein in antiviral innate immune signaling, is considered as one of the most important regulators of antiviral and antitumor immunity. Although STING agonists are now intensively studied in clinical trials as a new class of adjuvants to boost cancer immunotherapy, the tumor-intrinsic role of the STING pathway in shaping the tumor microenvironment remains controversial. Here, we discovered that STING plays a vital role in regulation of myeloid-derived suppressor cell (MDSC) differentiation and antitumor immunity in Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC). Mechanistic analyses reveal that STING represses NPC-derived MDSC induction by enhancing SOCS1 expression in both tumor cells and MDSCs. SOCS1 physically interacts with STAT3 through its SH2 domain to prevent STAT3 phosphorylation and dimerization, resulting in reduced MDSC induction via inhibition of GM-CSF and IL-6 production. Notably, reduced tumoral STING expression was found to be significantly associated with a poor prognosis for NPC patients. Our findings reveal a novel mechanism linking STING to tumor microenvironmental cytokine production and MDSC induction.
科研通智能强力驱动
Strongly Powered by AbleSci AI